Riskpilot← Back to searchSign inGet full accessQalib Doc AB
ABActiveOrg 5591231922Nidarosgatan 6 Lgh 1004Hospital activities · NACE 8610Est. 20172 employees
Revenue 2025
SEK 938K
+4% vs 2024
EBITDA margin
-9.9%
+80% vs 2024
Equity ratio
10.4%
Financial strength
Net profit 2025
SEK -103K
+80% vs 2024
| Revenue | SEK 938K | +4% |
| EBITDA | SEK -92K | +80% |
| Net profit | SEK -103K | +80% |
| Total assets | SEK 250K | -40% |
| Equity | SEK 26K | -80% |
| Employees | 2 | — |
Legal name
Qalib Doc AB
Org number
5591231922
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
30 augusti 2017
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva allmänmedicinsk mottagning, medicinsk konsultverksamhet i Sverige och utlandet, hemtjänst, personaluthyrning, fastighetsförvaltning, investeringar i bolag och värdepapper, samt därtill hörande verksamhet.
Address
Nidarosgatan 6 Lgh 1004
Email
nada.yussuf@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 391 | 1 882 | 1 746 | 904 | 938 |
| Staff expenses | — | −925 | −1 170 | −1 066 | −733 |
| EBITDA | 462 | 514 | 214 | −473 | −92 |
| Depreciation & amort. | −37 | −150 | −61 | −21 | — |
| EBIT | 425 | 364 | 153 | −493 | −92 |
| Net financials | — | −0 | 1 | −20 | −10 |
| Profit before tax | 425 | 363 | 154 | −513 | −103 |
| Tax | −88 | −75 | −32 | — | — |
| Net profit | 337 | 288 | 122 | −513 | −103 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 996 | 1 609 | 1 119 | 417 | 250 |
| Equity | 667 | 765 | 692 | 129 | 26 |
| Long-term debt | 18 | 555 | 250 | 198 | 168 |
| Short-term debt | 311 | 288 | 177 | 90 | 56 |
| Total debt | 329 | 844 | 426 | 288 | 224 |
EBITDA margin
-9.9%
This company
15.8%
Market median
-163% vs market
20212025
Equity ratio
10.4%
This company
38.2%
Market median
-73% vs market
20212025
Return on equity
-394.3%
This company
18.4%
Market median
-2243% vs market
20212025
Net profit margin
-11.0%
This company
8.1%
Market median
-236% vs market
20212025
Asset turnover
3.75×
This company
1.12×
Market median
+235% vs market
20212025
Debt / equity
8.59×
This company
0.62×
Market median
-1285% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Qalib Doc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Seinab Ismail Gabas | Deputy Board Member | 0 companies |
| Fatuma-Hibaq Mohamed Yussuf | Deputy Board Member | 0 companies |
| Awo Nada Mohamed Yussuf | Board of Directors | 0 companies |